Nah S Y, Attali B, Vogel Z
Department of Neurobiology, Weizmann Institute of Science, Rehovot, Israel.
Eur J Pharmacol. 1993 Jan 4;244(1):67-75. doi: 10.1016/0922-4106(93)90060-m.
We investigated the acute and chronic effects of alpha 2-adrenoceptor and muscarinic receptor agonists on dihydropyridine-sensitive voltage-dependent Ca2+ channels in spinal cord-dorsal root ganglion cocultures. Clonidine and oxotremorine inhibited the voltage-dependent Ca2+ influx (42 +/- 2% and 35 +/- 6% with 100 microM, respectively). The respective antagonists, yohimbine and atropine, abolished these effects. Pertussis toxin attenuated the inhibitory effects of clonidine and oxotremorine on Ca2+ influx, demonstrating involvement of G proteins in the transduction process. Chronic treatment with clonidine or oxotremorine desensitized the Ca2+ channel response to the agonist applied as well as to the other receptor agonist (heterologous desensitization). Such treatment with clonidine or oxotremorine decreased the pertussis toxin-catalyzed ADP-ribosylation of Gi alpha and G(o) alpha subunits, an effect which could be largely reversed by the detergent Lubrol PX. Yohimbine and atropine blocked the effects of clonidine or oxotremorine on pertussis toxin-catalyzed ADP-ribosylation. Results suggest that alpha 2-adrenoceptor and muscarinic receptors couple to the dihydropyridine-sensitive voltage-dependent Ca2+ channels via pertussis toxin-sensitive G proteins. Chronic agonist treatment leads to heterologous desensitization and to a reduced capacity of Gi and G(o) to undergo pertussis toxin-catalyzed ADP-ribosylation.
我们研究了α2 -肾上腺素能受体和毒蕈碱受体激动剂对脊髓 - 背根神经节共培养物中对二氢吡啶敏感的电压依赖性Ca2+通道的急性和慢性影响。可乐定和氧化震颤素抑制电压依赖性Ca2+内流(100μM时分别为42±2%和35±6%)。各自的拮抗剂育亨宾和阿托品消除了这些作用。百日咳毒素减弱了可乐定和氧化震颤素对Ca2+内流的抑制作用,表明G蛋白参与了转导过程。可乐定或氧化震颤素的慢性处理使Ca2+通道对所施加的激动剂以及其他受体激动剂的反应脱敏(异源脱敏)。可乐定或氧化震颤素的这种处理降低了百日咳毒素催化的Giα和G(o)α亚基的ADP -核糖基化,去污剂Lubrol PX可在很大程度上逆转这种作用。育亨宾和阿托品阻断了可乐定或氧化震颤素对百日咳毒素催化的ADP -核糖基化的作用。结果表明,α2 -肾上腺素能受体和毒蕈碱受体通过对百日咳毒素敏感的G蛋白与二氢吡啶敏感的电压依赖性Ca2+通道偶联。慢性激动剂处理导致异源脱敏,并降低了Gi和G(o)接受百日咳毒素催化的ADP -核糖基化的能力。